Boncresa is supplied as a 60 mg/mL single-dose prefilled syringe for SC injection and Oziltus is supplied as a 120 mg/1.7 mL single-dose vial for SC injection. Boncresa is approved to treat ...
BENGALURU, India and BRIDGEWATER, N.J., Sept. 17, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of ...
Bosaya and Aukelso are FDA-approved biosimilars for managing bone health in cancer patients, offering cost-effective alternatives to Prolia and Xgeva. Bosaya targets bone loss prevention in prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results